Skip to main content
Clinical Trials/NCT06360718
NCT06360718
Recruiting
Not Applicable

Effects of a Storybook About New Leukemia Diagnosis Versus Standard Child Life Intervention on Parental Stress: a Pilot Randomized Controlled Study

Children's Hospital Los Angeles1 site in 1 country140 target enrollmentFebruary 3, 2024
ConditionsLeukemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Leukemia
Sponsor
Children's Hospital Los Angeles
Enrollment
140
Locations
1
Primary Endpoint
Parental Stress, prior to and following child life intervention
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The goal of this clinical trial is to measure the effects of using a storybook versus standard child life intervention with parents of children newly diagnosed with leukemia on parental stress.

The main questions it aims to answer are:

  • What effect will the storybook have on parent/legal guardian stress at three timepoints: baseline, discharge, and follow up?
  • Will this storybook impact parent/legal guardian comfort levels and improve their child's understanding?

Participants will be asked to complete surveys at three timepoints, prior to and following child life intervention and about 3.5 months later. During child life interventions, participants will receive resources and support to explain leukemia to their school aged, 3-16-year-old, child (patient or sibling).

Researchers will compare Intervention and Control Groups to see if parental stress is lower in those who received the storybook in addition to the standard child life intervention versus the standard child life intervention alone.

Detailed Description

Research Design: This is a pilot randomized controlled study. Control Group will receive the standard child life care and interventions following a new leukemia diagnosis. This includes meeting one of the primary hematology oncology inpatient certified child life specialists (CCLS) to discuss patient/sibling understanding, language used, family experiences or stressors, and family goals when disclosure information about the diagnosis. Interventions may include books about cancer, personalized learning stories, or interactive activities to explain leukemia, cancer, and chemotherapy. Intervention Group will receive the standard child life care described in the Control Group above, plus the "Who Is Luke Eemia?" Storybook intervention tool created for this study. This storybook was designed by the PI to offer education on leukemia, cancer, chemotherapy, and hair loss through a child life lens. The CCLS will introduce the storybook and discuss common developmental considerations, offering parents suggestions on how to use it with their child, and answer additional questions. Study Procedures: 70 Parent/Child Dyads will be enrolled in this study. The study team will screen patients upon admission to the inpatient unit, identifying patients newly diagnosed with leukemia. Eligibility criteria requires a patient or sibling to be English or Spanish speaking, and between the ages of 3-16 years of age (without any cognitive or developmental delays or chronic medical conditions). Parent participation requires child assent to enroll. Enrolled parents will be randomized in the storybook group (intervention), or the standard child life support (control). The school-aged children will be enrolled as research subjects, though all study measures will be completed by parents, including parental impression of their child's understanding. To assess the effects of the storybook intervention tool, versus the standard child life intervention, parents will complete surveys at three timepoints: Baseline: * Parenting Stress Index Short Form (PSI™-4-SF) * Comfort Survey Discharge: * Discharge Survey * Storybook Assessment (Intervention Group Only) * The Parenting Stress Index Short Form (PSI™-4-SF) Follow Up (about 3.5 months after Baseline): - The Parenting Stress Index Short Form (PSI™-4-SF) Summary statistics means, medians, standard deviations and interquartile range will be calculated to summarize variables, we will trend data using graphs, and we will perform pre planned statistical tests in R.

Registry
clinicaltrials.gov
Start Date
February 3, 2024
End Date
July 1, 2026
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erin Shields

Child Life Specialist III

Children's Hospital Los Angeles

Eligibility Criteria

Inclusion Criteria

  • Parent/Legal Guardian of a child a. who is school-aged (3-16 years old) with a new leukemia diagnosis b. with a new leukemia diagnosis who is not school-aged but is a sibling of a school-aged child (\<3 years or \>16 years old).
  • Parent/legal guardian is able to speak, read, and write English or Spanish, and give informed consent
  • Parent/legal guardian is over 18 years of age.

Exclusion Criteria

  • Their school-aged children have developmental or cognitive delays, and/or other chronic illnesses.
  • Their school-aged child does not give assent to participate.

Outcomes

Primary Outcomes

Parental Stress, prior to and following child life intervention

Time Frame: 10 minutes at each timepoint (30 minutes total over the study).

All participating parents/legal guardians will be given the Parenting Stress Index -4 Short Form \[PSI™-4-SF\] at baseline (before child life intervention), discharge (about 1 week following the child life intervention for extended admissions), and about 3.5 months after the initial survey. The PSI™-4-SF form is a 36-item scale, available in English and Spanish. The form is broken into two domains (child and parent). The questions in the Parent Domain look at identifying sources of stress.

Secondary Outcomes

  • Parent's Comfort Explaining Aspects of Leukemia Diagnosis(at Baseline)
  • Parental Impression of the Storybook Tool using a Likert scale (1-week post baseline).(Baseline to 1 week)
  • Parent perception of the child's stress(10 minutes at each timepoint (30 minutes total over the study).)
  • Parent comfort, readiness, and importance, explaining aspects of the diagnosis at the discharge (1-week post baseline).(Baseline to 1 week)

Study Sites (1)

Loading locations...

Similar Trials